Sort
27,075 grants matching “cholesterol”
Studies of HCV Infection And HCV-Host interactions
$1,058,228T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,057,935Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Molecular Determinants of Statin Efficacy and Adverse Effects in Cellular Models
$1,057,429Marisa Wong Medina · Children'S Hospital & Res Ctr At Oakland · P50 · FY2016 · GM
Determining the Fate of Transmembrane Proteins
$1,057,306Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Physiology, Psychology, and Genetics of Obesity
$1,057,215Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$1,057,149Chung-Chou Ho Chang · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
LIVER/INTESTINAL METABOLISM ON BILE ACIDS/CHOLESTEROL
$1,055,912Virginia Commonwealth University · P01 · FY2000 · DK
Lifespan and Cardiovascular Health Effects on The Brain in Humans and Great Ape
$1,055,607Patrick R Hof · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Computer Simulations of Membranes and Biopolymers
$1,055,097Richard Walter Pastor · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Theoretically Informed Behavioral Intervention to Enhance QOL and Prevent HIV-related Comorbidities in Ethnic and Racial Sexual Minority Men
$1,054,907Silvia Raquel Ramos · Yale University · R01 · FY2024 · MD
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,053,013Karin E. Bornfeldt · University Of Washington · R35 · FY2025 · HL
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION
$1,052,832University Of Cincinnati · P01 · FY2003 · DK
Cell Cholesterol Efflux and HDL Formation
$1,051,544University Of California San Francisco · P01 · FY2004 · HL
SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing . . .
$1,050,359Marc Ivor Chimowitz · Medical University Of South Carolina · U01 · FY2011 · NS
Novel biologic to treat chemotherapy-induced neuropathic pain
$1,049,997Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2023 · CA
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$1,049,285David G. Drubin · University Of California Berkeley · R35 · FY2020 · GM
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$1,049,285David G. Drubin · University Of California Berkeley · R35 · FY2019 · GM
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$1,049,285David G. Drubin · University Of California Berkeley · R35 · FY2017 · GM
Molecular Dynamics Simulations Of Biological Macromolecules
$1,048,765Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Regulation of MHC Class II Trafficking in Antigen Presenting Cells
$1,048,402Paul Roche · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Targeting lipid rafts for treatment of asthma
$1,046,403Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2025 · AI
Task Area B2 Visit 3 Basic Exam.
$1,046,218Martha Daviglus · University Of Illinois At Chicago · N01 · FY2020 · HL
Cellular Biology Of Host/parasite Interactions
$1,046,078David (ted) Hackstadt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION
$1,045,559Columbia University Health Sciences · R01 · FY2002 · NS
Biology of Prion Protein and the TSE Diseases
$1,045,516Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI